Lilly CEO Says Weight-loss Drug Zepbound Weekly Prescriptions Hit 25,000 in December Lilly CEO Says Weight-loss Drug Zepbound Weekly Prescriptions Hit 25,000 in December

Eli Lilly CEO David Ricks on Monday said the company ' s powerful weight-loss drug Zepbound hit 25,000 new prescriptions per week at the end of December and that its 2024...Reuters Health Information
Source: Medscape Diabetes Headlines - Category: Endocrinology Tags: Diabetes & Endocrinology Source Type: news